GAPDH and Alzheimer disease: The blood S-glutathionylated GAPDH levels in the total set of controls (59.92 ± 122.4 ng/dL) were also significantly lower than those in the total set of patients with AD (752.7 ± 301.7 ng/dL) (p < 0.001) (Fig 1B) (Table 1).